CGC vs. ACB, CRON, OGI, SNDL, TLRY, VFF, STZ, NTLA, ETNB, and XERS
Should you be buying Canopy Growth stock or one of its competitors? The main competitors of Canopy Growth include Aurora Cannabis (ACB), Cronos Group (CRON), Organigram Global (OGI), SNDL (SNDL), Tilray Brands (TLRY), Village Farms International (VFF), Constellation Brands (STZ), Intellia Therapeutics (NTLA), 89BIO (ETNB), and Xeris Biopharma (XERS).
Canopy Growth vs. Its Competitors
Canopy Growth (NASDAQ:CGC) and Aurora Cannabis (NASDAQ:ACB) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, analyst recommendations, earnings, profitability, dividends and valuation.
Aurora Cannabis has higher revenue and earnings than Canopy Growth. Aurora Cannabis is trading at a lower price-to-earnings ratio than Canopy Growth, indicating that it is currently the more affordable of the two stocks.
3.3% of Canopy Growth shares are owned by institutional investors. Comparatively, 47.6% of Aurora Cannabis shares are owned by institutional investors. 0.2% of Canopy Growth shares are owned by company insiders. Comparatively, 0.0% of Aurora Cannabis shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
In the previous week, Canopy Growth had 7 more articles in the media than Aurora Cannabis. MarketBeat recorded 10 mentions for Canopy Growth and 3 mentions for Aurora Cannabis. Canopy Growth's average media sentiment score of 1.57 beat Aurora Cannabis' score of 0.99 indicating that Canopy Growth is being referred to more favorably in the media.
Aurora Cannabis has a net margin of -5.66% compared to Canopy Growth's net margin of -155.76%. Aurora Cannabis' return on equity of -1.49% beat Canopy Growth's return on equity.
Canopy Growth has a beta of 0.77, indicating that its share price is 23% less volatile than the S&P 500. Comparatively, Aurora Cannabis has a beta of 1.91, indicating that its share price is 91% more volatile than the S&P 500.
Summary
Aurora Cannabis beats Canopy Growth on 11 of the 16 factors compared between the two stocks.
Get Canopy Growth News Delivered to You Automatically
Sign up to receive the latest news and ratings for CGC and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding CGC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Canopy Growth Competitors List
Related Companies and Tools
This page (NASDAQ:CGC) was last updated on 9/16/2025 by MarketBeat.com Staff
